Form 4 for REVB REVELATION BIOSCIENCES, INC.
Accepted 2025-10-31 00:00:00 ET · period of report 2025-10-29 · accession 0001193125-25-260419 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-31 | 2025-10-29 | REVB | CARVER JENNIFER | Dir | A - Grant | $1.28 | +15.6K | 15.7K | +24,802% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-29 | A | A | 15,625 | $1.28 | 15,688 | D | — | — | (F1) Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on January 28, 2026. |